14May
Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By:
Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/
Related
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
In May 2020, the US Securities and Exchange Commission announced amendments to the rule and forms re...
Read More >
Every day in the United States, 130 people die from opioid overdoses. To date, the opioid epidemic, ...
Read More >
In a recent claim filed against one of our clients, an aggrieved employee alleged that a manager who...
Read More >
What is in store for companies that are on the cusp of financial distress and might be facing potent...
Read More >
Today we share our conversation with Haley Altman, founder and CEO of Doxly, which was recently acqu...
Read More >